J&J slashes production of its unpopular COVID-19 shot
January 13, 2023 at 13:39 PM EST
A partnership with rival Merck & Co. to help make the shots, forged at the urging of the U.S. government, hasn’t lived up to expectations. The companies are now engaged in arbitration.